Camelia Grancea

412 total citations
28 papers, 296 citations indexed

About

Camelia Grancea is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Camelia Grancea has authored 28 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Hepatology and 7 papers in Immunology. Recurrent topics in Camelia Grancea's work include Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (6 papers). Camelia Grancea is often cited by papers focused on Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (6 papers). Camelia Grancea collaborates with scholars based in Romania, United States and Slovakia. Camelia Grancea's co-authors include Coralia Bleoţu, Simona Ruţă, C Tănăsescu, A. Balanescu, C Cernescu, Paul Bălănescu, Rodica Olteanu, Camelia Badea, Carmen Ardeleanu and Anca Georgescu and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Neuroimmunology and Journal of Cellular and Molecular Medicine.

In The Last Decade

Camelia Grancea

25 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camelia Grancea Romania 8 101 88 75 55 52 28 296
Juan M. Cubillos-Angulo Brazil 12 69 0.7× 104 1.2× 56 0.7× 103 1.9× 31 0.6× 25 306
Kevin Steiner United States 8 139 1.4× 77 0.9× 27 0.4× 39 0.7× 17 0.3× 11 308
Peter Bourke Australia 8 114 1.1× 45 0.5× 54 0.7× 26 0.5× 144 2.8× 11 272
Sidney Ogolla Kenya 13 108 1.1× 74 0.8× 17 0.2× 85 1.5× 83 1.6× 32 383
Timon Damelang Australia 9 167 1.7× 71 0.8× 22 0.3× 59 1.1× 38 0.7× 17 350
Sébastien Bertin-Maghit France 10 166 1.6× 132 1.5× 28 0.4× 48 0.9× 122 2.3× 10 387
Karl Sitz United States 11 124 1.2× 67 0.8× 35 0.5× 107 1.9× 15 0.3× 24 358
O. Lambotte France 8 100 1.0× 144 1.6× 26 0.3× 56 1.0× 41 0.8× 25 377
Francesca Bellomi Italy 11 96 1.0× 134 1.5× 84 1.1× 66 1.2× 14 0.3× 20 369
O.P. Sumba Kenya 8 192 1.9× 63 0.7× 26 0.3× 71 1.3× 78 1.5× 8 447

Countries citing papers authored by Camelia Grancea

Since Specialization
Citations

This map shows the geographic impact of Camelia Grancea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camelia Grancea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camelia Grancea more than expected).

Fields of papers citing papers by Camelia Grancea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camelia Grancea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camelia Grancea. The network helps show where Camelia Grancea may publish in the future.

Co-authorship network of co-authors of Camelia Grancea

This figure shows the co-authorship network connecting the top 25 collaborators of Camelia Grancea. A scholar is included among the top collaborators of Camelia Grancea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camelia Grancea. Camelia Grancea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matei, Lilia, Mihaela Chivu‐Economescu, Camelia Grancea, et al.. (2025). Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years. International Journal of Molecular Sciences. 26(16). 8106–8106.
2.
Ene, Luminiţa, et al.. (2025). Impact of Combined Antiretroviral Treatment (cART) on Latent Cytomegalovirus Infection. Viruses. 17(1). 76–76.
3.
Grancea, Camelia, et al.. (2024). HIV, HCV and HIV-HCV Coinfections in the General Population versus Inmates from Romania. Viruses. 16(8). 1279–1279. 1 indexed citations
4.
Ruţă, Simona, et al.. (2024). SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV. Vaccines. 12(6). 663–663. 1 indexed citations
5.
Chivu‐Economescu, Mihaela, Coralia Bleoţu, Camelia Grancea, et al.. (2022). Kinetics and persistence of cellular and humoral immune responses to SARS‐CoV‐2 vaccine in healthcare workers with or without prior COVID‐19. Journal of Cellular and Molecular Medicine. 26(4). 1293–1305. 28 indexed citations
6.
Botezatu, Anca, Adriana Pleșa, Marinela Bostan, et al.. (2020). Alterations of regulatory factors and DNA methylation pattern in thyroid cancer. Cancer Biomarkers. 28(2). 255–268. 21 indexed citations
7.
Grancea, Camelia, et al.. (2018). In the backstage of lactoferrin derived peptides' antiviral activity.. 77(3). 213–221. 2 indexed citations
8.
Iacob, Speranța, Liliana Pâslaru, Roxana Vădan, et al.. (2018). The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Chirurgia. 113(4). 534–534. 2 indexed citations
9.
Bleoţu, Coralia, et al.. (2016). Viral serological and molecular data on possible involvement of herpes viruses in periodontal disease. PubMed. 37. 15–19. 6 indexed citations
10.
Ene, Luminiţa, Thomas D. Marcotte, Anya Umlauf, et al.. (2016). Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection. Journal of Neuroimmunology. 299. 1–7. 24 indexed citations
11.
Grancea, Camelia, et al.. (2016). THE PERFORMANCE OF A RAPID TEST FOR ANTI-HCV SCREENING IN ORAL FLUIDS.. PubMed. 74(1-2). 40–5. 3 indexed citations
12.
Grancea, Camelia, et al.. (2015). SERUM ALPHA FETOPROTEIN, A SURROGATE MARKER FOR LIVER DISEASE PROGRESSION IN CHRONIC HEPATITIS C.. PubMed. 73(3-4). 69–73. 1 indexed citations
13.
Ene, Luminiţa, et al.. (2014). High prevalence of asymptomatic HBV chronic carriage in HIV infected long term survivors. BMC Infectious Diseases. 14(S4). 5 indexed citations
14.
Erşcoiu, Simona, et al.. (2013). Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania. Hepatitis Monthly. 13(2). e8611–e8611. 6 indexed citations
15.
Bleoţu, Coralia, et al.. (2012). Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers. European Archives of Oto-Rhino-Laryngology. 270(2). 711–718. 17 indexed citations
16.
Chifiriuc, Mariana Carmen, Coralia Bleoţu, Grațiela Grădișteanu Pîrcălăbioru, et al.. (2011). Cytokine profiles of HeLa and human diploid cells induced by different fractions of Vibrio parahaemolyticus cultures exposed to stress conditions.. PubMed. 69(3). 164–72. 1 indexed citations
17.
Grancea, Camelia, et al.. (2011). Hepatitis C virus genotypes in injecting drug users from Romania. Open Medicine. 6(5). 672–678. 6 indexed citations
18.
Tănăsescu, C, A. Balanescu, Paul Bălănescu, et al.. (2010). IL-17 in cutaneous lupus erythematosus. European Journal of Internal Medicine. 21(3). 202–207. 81 indexed citations
19.
Bleoţu, Coralia, Mariana Carmen Chifiriuc, Camelia Grancea, et al.. (2010). TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy.. PubMed. 69(1). 24–34. 23 indexed citations
20.
Constantinescu, Ileana, et al.. (2000). "Trial moves rapidly on, when the judge has determined the sentence beforehand" (W. Scott: Ivanhoe, 36) or pitfalls in serosurvey of anti-hepatitis C antibody in children.. PubMed. 49(1-4). 11–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan M. Cubillos-Angulo Breakdown of academic impact, for papers by Kevin Steiner Breakdown of academic impact, for papers by Peter Bourke Breakdown of academic impact, for papers by Sidney Ogolla Breakdown of academic impact, for papers by Timon Damelang Breakdown of academic impact, for papers by Sébastien Bertin-Maghit Breakdown of academic impact, for papers by Karl Sitz Breakdown of academic impact, for papers by O. Lambotte Breakdown of academic impact, for papers by Francesca Bellomi Breakdown of academic impact, for papers by O.P. Sumba
Rankless by CCL
2026